Questions discussed in this category
If a patient presents with metastatic disease (by virtue of extensive PA nodal burden, mediastinal/SCV involvement, no solid organs) but received urge...
Do you increase EBRT or brachy dose by a certain amount based on interval?
Ideally, treatment should be completed in 56 days (preferably < 50 days). If there has been a significant delay to brachytherapy (>2-3 months) d...
Do you recommend upfront diversion? Are there unique planning considerations such as the inability to use bladder filling? How do you boost? What are ...
Do you try to keep Hb> 10 or 12? Or somewhere in between?
Patient is 38yo, has a history of narcotic abuse, and may have an undiagnosed personality disorder.
Is the QuadShot a possible option?
Could EBRT lead to rupture of the cyst?
This patient has pulmonary nodules that are too small to characterize.
Previously received pelvic EBRT and intracavitary brachytherapy. IORT was administered to the node-positive side wall at the time of exenteration.
Patient did not previously receive para-aortic radiation. Considering RT vs RT + chemo vs chemo alone
Recurrence was 2cm and PET confirmed local. Excision with positive margins. Current plan for salvage whole pelvic RT and vaginal cuff brachytherapy +/...
In patient with PD SCCA 15mm transverse; 5/20mm invasion; LVSI focally present; margins negative; 0/15 Left pelvic and 0/14 right pe...
What dose and technique do you use and how do you integrate the subsequent definitive treatment plan?
The recently released STARS phase 3 RCT found improved DFS, decreased distant recurrence, with reduced toxicities for chemotherapy (cisplatin + taxol)...
SIBs of 55-57.5 Gy in 25 fractions are frequently mentioned with bowel volume constraints at this dose, but assuming there is no bowel nearby (e.g., b...
How would you factor in a patient with profound thrombocytopenia?
Paraaortic nodes positive to left renal vein
ex. in a patient with pulmonary micronodules, inguinal, pelvic, PA nodes
Particularly with IMRT when delineating volumes.
Patient with stage IIB cervical cancer treated 8 years ago, now with large (>10cm), isolated, symptomatic recurrence involving the left SCL and med...
Would you consider SBRT or brachytherapy?
Small bowel is usually the dose limiting OAR while planning cervical HDR brachytherapy. Having the bladder empty during treatment planning and deliver...
Would you consider additional EBRT or vaginal cuff HDR in a patient with previous tx with EBRT (45Gy) + HDR (30Gy) for a R1 resection with a radial ma...
This has been a common practice in the community. Is there a benefit for certain patients?
What dose/fractionation would you recommend?
Patient being treated for cervical cancer noted to have a < 1 cm posterior vaginal fornix defect with a small focus epiploclia herniating into the ...
Would there be a substanital increase in the risk of toxicity using such a scheme?
We frequently have patients who have to travel long distance...
Could you discuss how you decide between IMRT or SBRT boost for a patient who is not able to receive intracavitary or interstitial HDR or LDR brachyth...
What chemotherapy and sequencing with radiation therapy would you recommend? IS surgery a component of the treatment?
Do you have an SUV cutoff for physiologic activity of the ovary?
Do you cover common iliac nodes (L3/L4) or keep field edge at L4/L5 to reduce bone marrow toxicity?
If so, what indications would you use other than Peters criteria?
Do you use a trimmed 10 mm expansion on HR-CTV? Do you also include the entire initial extent of disease? How much does your IR-CTV coverage affect yo...
A literature search indicates that most port site recurrences are managed fairly aggressively with chemoRT or RT doses 45-66 Gy. This is understandabl...
Sequentially or do you integrate the cuff brachy with the EBRT and if so what schedule, BIW, weekly, etc?
For example, a patient with cervical or anal SCC who has missed many treatments due to side effects, low blood counts, hospitalizations, or non-compli...
Do you add an IMRT boost with possibly vaginal brachytherapy?
What are your specific protocols for monitoring and for dosing narcotics and sedatives?
If so, what dose/ volume is prescribed? How do you account for motion?
Close but negative radial margins? LVSI? What fractionation/dose do you use for your vaginal cuff boost if used?
In the setting of a negative lymph node sampling, would you treat a full pelvis or mini-pelvis to compensate for lack of the appropriate surgery? Is a...
In patients who don't meet traditional criteria for adjuvant chemoradiation from Peters (GOG 109) and < 2 high risk factors from Rotman (GOG 92) fo...
What exactly do you contour and what is your dose constraint to that volume?
Does using something like a vienna applicator allow you to avoid dose escalation with more external beam? How do you recommend doing a classic pa...
Some classic references recommend the coverage of the entirety of the sacrum but the volume delineation guidelines for both seem to only cover the mos...
The most recent ABS guidelines don't discuss a dose constraint for the small bowel.
Does your strategy change if bladder invasion is present?
Do you treat PAs if pelvic nodes are positive? If common iliacs are involved? Only if there are positive PA nodes?
11851106749938122061256412373121512550114541110140911083667110334106111055810550104658003103331026171129851995798829875985023399466941192759276866786008129800778647839683368237511647068426299569358345714528852195042485647994567460545661959402241004090403840102626248624752413178621502030285846817424426425288247348271325
Papers discussed in this category
International journal of radiation oncology, biology, physics, 2011-02-01
Int J Radiat Oncol Biol Phys, 2013 Jul 9
JAMA Netw Open, 2021 Apr 01
Int. J. Radiat. Oncol. Biol. Phys., 2014-05-01
Cancer Nurs, 2017-04-21
Cochrane Database Syst Rev, 2010 Sep 08
International journal of radiation oncology, biology, physics, 2019-05-01
Cochrane Database Syst Rev, 2012 May 16
Int. J. Gynecol. Cancer,
Seminars in radiation oncology, 2019-04
International journal of radiation oncology, biology, physics, 2006-08-01
Gynecologic oncology, 2005-11
J. Clin. Oncol., 2011 Mar 28
BMC Cancer, 2017 Apr 28
Clin Transl Radiat Oncol, 2018 Jan 11
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2019-01
International journal of radiation oncology, biology, physics, 1991-07
Cancer,
N. Engl. J. Med.,
J Gynecol Oncol,
International journal of radiation oncology, biology, physics, 2008-11-15
Int. J. Radiat. Oncol. Biol. Phys., 2012 Aug 14
Practical radiation oncology, 2017
Practical radiation oncology, 2018
The New England journal of medicine, 1999-04-15
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000-04
Ann Oncol, 2012 Feb 21
JAMA Oncol,
Int J Gynecol Cancer, 2019 Jan 04
Gynecologic oncology, 1998-08
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004-08-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-10-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985-08
Cancer, 1981-08-15
Clin Transl Radiat Oncol, 2020 Apr 16
Pract Radiat Oncol, 2019 Nov
Cancers (Basel), 2021 Mar 11
International journal of radiation oncology, biology, physics, 2017-12-01
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2017-03
N Engl J Med, 2021 Sep 18
N Engl J Med, 2022 Jan 19
Radiother Oncol, 2016 Sep